StonvexLoading…
StonvexStonvexStonvexCore line items from ONC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.34B | $3.81B | $2.46B | $1.42B |
Operating Income | $447.14M | $-568.20M | $-1.21B | $-1.79B |
Net Income | $286.93M | $-644.79M | $-881.71M | $-2.00B |
EPS (Diluted) | $0.19 | $-0.47 | $-0.65 | $-1.49 |
Total Assets | $8.19B | $5.92B | $5.81B | $6.38B |
Total Liabilities | $3.83B | $2.59B | $2.27B | $2.00B |
Cash & Equivalents | $4.55B | $2.63B | $3.17B | $3.87B |
Free Cash Flow OCF − CapEx | $941.74M | $-633.29M | $-1.72B | $-1.82B |
Shares Outstanding | 1.44B | 1.39B | 1.36B | 1.36B |